Dr. James Todaro stood on the steps of the Supreme Court last week to join fellow doctors in touting hydroxychloroquine as a viable early-stage treatment for those who contract the coronavirus — and says he was stunned by the backlash.
H/T: The Washington Times
“I’ve never seen so many different institutional levels attack,” said Dr. Todaro, a former physician turned investment manager with Blocktown Capital. “It seems like a coordinated effort to discredit hydroxychloroquine.”
“If it seems like the medical system (e.g., NIH, WHO, medical journals, institutional experts) is rigged against hydroxychloroquine,” he tweeted recently, “it’s because it is.”
“You might also call it a competition killer, hydroxychloroquine,” Dr. Todaro said. “It’s very hard to make money off it, even if there is grassroots support for it it’s really hard to have a financial interest in it.”
Pre-COVID: Harvard rheumatologists call HCQ "a daily multivitamin for people with mild to moderate lupus."— James Todaro, MD (@JamesTodaroMD) August 2, 2020
Post-COVID: Hydroxychloroquine is medicine's most dangerous drug and physicians should not be allowed to prescribe it.
This is not normal behavior in medicine. pic.twitter.com/zX0Uvfwh2E
2/ There's only one double-blind RCT on HCQ in early treatment of COVID-19.— James Todaro, MD (@JamesTodaroMD) August 1, 2020
All of the other RCTs (SOLIDARITY, RECOVERY, etc) were in very sick patients and are borderline worthless because they just support what we've been saying since March—HCQ is for early disease, not late.
4/ The Minnesota study is honestly an embarrassment to the term “randomized controlled trial” and should actually be called an “anonymous online survey” instead.— James Todaro, MD (@JamesTodaroMD) August 1, 2020
6/ The participants were evaluated via a static online survey and not actually seen by physicians or medical personnel.— James Todaro, MD (@JamesTodaroMD) August 1, 2020
So the quality of the diagnosis was essentially equivalent to someone typing symptoms into WebMD.
8/ Next point.— James Todaro, MD (@JamesTodaroMD) August 1, 2020
If the researchers had kept their original end point (hospitalization/death), the study would've actually shown a strong trend toward benefit for HCQ.
Instead, the researchers changed the end point mid-study from hospitalizations/death to symptoms at 14 days.
10/ The good news is that Dr. Fauci & the NIH started a trial in May doing just this.— James Todaro, MD (@JamesTodaroMD) August 1, 2020
The bad news is they cancelled the trial after enrolling only 20 subjects in order to focus on a new trial evaluating remdesivir plus baricitinib (another “novel” patented drug). pic.twitter.com/2VIH520z1p
11/ In conclusion, it's been >4 mos since HCQ was proposed for early stage COVID-19.— James Todaro, MD (@JamesTodaroMD) August 1, 2020
Yet, with their vast resources, neither the WHO nor NIH conducted a trial on this.
Instead Dr. Fauci's evidence for the inefficacy of HCQ comes from an online survey under the guise of an RCT.
Looking here, Dr. Fauci is killing our people as many in our country continue to support his efforts. pic.twitter.com/ksJkSZxrDi— Tracy Woods (@Tracyartandarch) August 2, 2020
We all know whats going on. Lets stop romancing testing processes, clinical whatever etc. Hydroxy chloroquine works. Period!!! pic.twitter.com/2yvawpPkyU— T (@T_Ngwenya_) August 1, 2020